New research suggests that a healthy microbiome before chemotherapy could help protect breast cancer patients against heart damage, or cardiotoxicity, as a result of cancer therapy. …
New research has shown that, in survivors of breast cancer, having an unhealthy metabolic profile, also known as ‘metabolic syndrome,’ increases the risk of breast cancer recurrence by 69 percent and the risk of subsequent breast cancer mortality by 83 percent. …
A new study warns that radiation from medical imaging, particularly CT scans—which may account for 5 percent of all annual cancers—can significantly increase the risk of future lung, breast, and other cancers, with babies facing a tenfold heightened risk. …
New research shows that a high-fat diet and platelet activation influence the metastasis of triple-negative breast cancer cells, suggesting potential new treatments and prognostic markers. …
A preclinical study has shown that linoleic acid, an omega-6 fatty acid found in seed oils such as soybean and safflower oil, as well as in animal products like pork and eggs, specifically enhances the growth of the hard-to-treat “triple-negative” breast cancer subtype. …
New findings reveal a mechanism that enables triple-negative breast cancer to develop therapy resistance. …
Experimental drug RK-33 has demonstrated promise in treating breast cancer that has spread to the bone in mouse models. …
New research has identified a natural immune mechanism in mice that prevents cancer metastasis. …
Trastuzumab deruxtecan, an antibody-drug conjugate, can significantly extend the lives of patients with HER2-positive breast cancer. …
Scientists have pinpointed thousands of genetic changes in a gene that may increase the risk of developing breast and ovarian cancers, paving the way for better risk assessment and more personalized care. …
End of content
End of content
